Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer

Therapeutic Targeting of Fibroblast Growth Factor Receptors in Gastric Cancer

Chemotherapy has become the global standard treatment for patients with metastatic or unresectable gastric cancer (GC), although outcomes remain unfavorable. Many molecular-targeted therapies inhibiting signaling pathways of various tyrosine kinase receptors have been developed, and monoclonal antib...

Full description

Bibliographic Details
Main Authors:	Inokuchi, Mikito, Fujimori, Yoshitaka, Otsuki, Sho, Sato, Yuya, Nakagawa, Masatoshi, Kojima, Kazuyuki
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427097/

Similar Items

Impact of comorbidities on postoperative complications in patients undergoing laparoscopy-assisted gastrectomy for gastric cancer
by: Inokuchi, Mikito, et al.
Published: (2014)

Prognostic value of RKIP and p-ERK in gastric cancer
by: Fujimori, Yoshitaka, et al.
Published: (2012)

High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival
by: Baongoc Nasri, et al.
Published: (2017-04-01)

Postoperative Complications of Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Gastric Cancer in a Meta-Analysis of High-Quality Case-Controlled Studies
by: Inokuchi, Mikito, et al.
Published: (2016)

Clinical significance of platelet derived growth factor-C and -D in gastric cancer
by: OGAWA, NORIHITO, et al.
Published: (2015)

EphA4 is a prognostic factor in gastric cancer
by: Miyazaki, Kohji, et al.
Published: (2013)

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
by: Szlachcic, Anna, et al.
Published: (2016)

Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors
by: Wöhrle, Simon, et al.
Published: (2013)

Targeting fibroblast growth factors in cancer
by: Baker, Kevin P., et al.
Published: (2013)

Fibroblast growth factors as tissue repair and regeneration therapeutics
by: Nunes, Quentin M., et al.
Published: (2016)

Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer
by: Jain, Vikram K, et al.
Published: (2012)

Rationale for targeting fibroblast growth factor receptor signaling in breast cancer
by: André, Fabrice, et al.
Published: (2015)

Toll-like receptor 2: therapeutic target for gastric carcinogenesis
by: McCormack, William, et al.
Published: (2012)

Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
by: Cheng, Tiewei, et al.
Published: (2013)

Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
by: Togo, Shinsaku, et al.
Published: (2013)

Mutational identification of fibroblast growth factor receptor 1 and fibroblast growth factor receptor 2 genes in craniosynostosis in Indian population
by: Pandey, Rajeev Kumar, et al.
Published: (2013)

The anti-apoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer
by: Ren, Chuanli, et al.
Published: (2016)

Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma
by: Liu, Naiqing, et al.
Published: (2015)

MET amplification as a potential therapeutic target in gastric cancer
by: Kawakami, Hisato, et al.
Published: (2012)

Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
by: Wykosky, Jill, et al.
Published: (2011)

The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma
by: Bill, Kate Lynn J., et al.
Published: (2015)

Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions
by: Yamakawa, Hiroyuki, et al.
Published: (2015)

Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors
by: Yamaguchi, Hideki, et al.
Published: (2014)

Effects of temperature and additives on stability and spectrum of a therapeutic fibroblast growth factor
by: Zhou, CY., et al.
Published: (2011)

Therapeutic anti-inflammatory effects of luteolin on endotoxin-induced uveitis in Lewis rats
by: KANAI, Kazutaka, et al.
Published: (2016)

Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3
by: Qian, Shenxian, et al.
Published: (2005)

Bleeding from gastric body varices effectively treated with endoscopic band ligation
by: Sato, Takahiro, et al.
Published: (2012)

Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer
by: Chang, Jinjia, et al.
Published: (2014)

The epigenome of synovial fibroblasts: an underestimated therapeutic target in rheumatoid arthritis
by: Frank-Bertoncelj, Mojca, et al.
Published: (2014)

CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer
by: Yoshida, Kazumichi, et al.
Published: (2015)

Eph receptors as therapeutic targets in glioblastoma
by: Day, B W, et al.
Published: (2014)

Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma
by: Poh, Weijie, et al.
Published: (2012)

Fibroblast Growth Factor Receptor 2: Expression, Roles, and Potential As a Novel Molecular Target for Colorectal Cancer
by: Matsuda, Yoko, et al.
Published: (2012)

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer
by: Turkington, R C, et al.
Published: (2014)

Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
by: Ling, Ling, et al.
Published: (2015)

Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis
by: Yang, Guang-Wei, et al.
Published: (2015)

mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
by: Scheller, T, et al.
Published: (2015)

Monoclonal Antibody Targeting of Fibroblast Growth Factor Receptor 1c Ameliorates Obesity and Glucose Intolerance via Central Mechanisms
by: Lelliott, Christopher J., et al.
Published: (2014)

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
by: Coleman, Stacey J, et al.
Published: (2014)

Fibroblast growth factors
by: Ornitz, David M, et al.
Published: (2001)